Cytokinetics
CYTK
#2350
Rank
โ‚น701.30 B
Marketcap
โ‚น5,736
Share price
4.25%
Change (1 day)
39.03%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚น701.30 Billion

As of December 2025 Cytokinetics has a market cap of โ‚น701.30 Billion. This makes Cytokinetics the world's 2350th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น701.30 B46.27%
2024โ‚น479.47 B-29.65%
2023โ‚น681.51 B89.94%
2022โ‚น358.80 B25.32%
2021โ‚น286.31 B166.18%
2020โ‚น107.56 B140.26%
2019โ‚น44.77 B85.15%
2018โ‚น24.18 B-13.77%
2017โ‚น28.04 B-16.38%
2016โ‚น33.53 B21.88%
2015โ‚น27.51 B40.19%
2014โ‚น19.62 B59.29%
2013โ‚น12.32 B139.33%
2012โ‚น5.14 B40.25%
2011โ‚น3.67 B-41.42%
2010โ‚น6.26 B-24.26%
2009โ‚น8.27 B20.94%
2008โ‚น6.84 B-25.22%
2007โ‚น9.14 B-36.2%
2006โ‚น14.33 B81.5%
2005โ‚น7.90 B-33.7%
2004โ‚น11.91 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Cytokinetics was reported to be:

โ‚น701.30 Billion
by Nasdaq info icon info icon
โ‚น701.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น337.78 B-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚น0.93 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น74.33 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.491 T 2,108.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น117.83 B-83.20%๐Ÿ‡บ๐Ÿ‡ธ USA